MDS with Ring Sideroblasts

subtype

Identifier: CI-CAN-00009471
Entity page: /cancer/mds-with-ring-sideroblasts ↗
Edges: 6

Neighbours: 2 drugs4 trials
Drawn: 6 of 6 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
MDS with Ring Sideroblasts investigated in trials for …INVESTIGATED_IN_TRIALSderived2 of 2
→ investigated in trials for	Fludarabinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	MDS with Ring Sideroblasts	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants

MDS with Ring Sideroblasts studied in …STUDIED_INderived4 of 4
→ studied in	NCT02566304Phase 2 · completed Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 4 trials mapped (0 active)	—	—	Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT00589316Phase 1 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome · condition mapped ALIAS · 4 trials mapped (0 active)	—	—	Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT00397813Phase 2 · completed Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 4 trials mapped (0 active)	—	—	Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia	1	Observed	clinicaltrials	graph →
→ studied in	NCT00988715Phase 1 · completed Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome · condition mapped ALIAS · 4 trials mapped (0 active)	—	—	Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia	1	Observed	clinicaltrials	graph →

MDS with Ring Sideroblasts studied in …STUDIED_INderived4 of 4

→ studied in

NCT02566304Phase 2 · completed

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 4 trials mapped (0 active)

—

Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia

Observed

clinicaltrials

graph →

→ studied in

NCT00589316Phase 1 · terminated

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome · condition mapped ALIAS · 4 trials mapped (0 active)

—

Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia

Observed

clinicaltrials

graph →

→ studied in

NCT00397813Phase 2 · completed

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 4 trials mapped (0 active)

—

Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia

Observed

clinicaltrials

graph →

→ studied in

NCT00988715Phase 1 · completed

Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome · condition mapped ALIAS · 4 trials mapped (0 active)

—

Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains